Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Cost of Revenue (2018 - 2026)

Viemed Healthcare filings provide 8 years of Cost of Revenue readings, the most recent being $32.1 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 30.63% to $32.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $114.8 million, a 26.1% increase, with the full-year FY2025 number at $114.8 million, up 26.1% from a year prior.
  • Cost of Revenue hit $32.1 million in Q4 2025 for Viemed Healthcare, up from $30.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $32.1 million in Q4 2025 to a low of $9.8 million in Q2 2021.
  • Median Cost of Revenue over the past 5 years was $17.9 million (2023), compared with a mean of $18.7 million.
  • Biggest five-year swings in Cost of Revenue: crashed 42.26% in 2021 and later surged 33.69% in 2024.
  • Viemed Healthcare's Cost of Revenue stood at $12.3 million in 2021, then rose by 18.8% to $14.6 million in 2022, then grew by 27.48% to $18.6 million in 2023, then soared by 31.83% to $24.6 million in 2024, then skyrocketed by 30.63% to $32.1 million in 2025.
  • The last three reported values for Cost of Revenue were $32.1 million (Q4 2025), $30.6 million (Q3 2025), and $26.3 million (Q2 2025) per Business Quant data.